ES531004A0 - Un metodo de preparar compuestos de diaminopirimidina - Google Patents

Un metodo de preparar compuestos de diaminopirimidina

Info

Publication number
ES531004A0
ES531004A0 ES531004A ES531004A ES531004A0 ES 531004 A0 ES531004 A0 ES 531004A0 ES 531004 A ES531004 A ES 531004A ES 531004 A ES531004 A ES 531004A ES 531004 A0 ES531004 A0 ES 531004A0
Authority
ES
Spain
Prior art keywords
diaminopyrimidine compounds
preparing
preparing diaminopyrimidine
compounds
diaminopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531004A
Other languages
English (en)
Other versions
ES8504775A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES531004A0 publication Critical patent/ES531004A0/es
Publication of ES8504775A1 publication Critical patent/ES8504775A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES531004A 1982-09-09 1984-03-27 Un metodo de preparar compuestos de diaminopirimidina Expired ES8504775A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41640482A 1982-09-09 1982-09-09
US06/520,653 US4532240A (en) 1982-09-09 1983-08-09 Diaminopyrimidines

Publications (2)

Publication Number Publication Date
ES531004A0 true ES531004A0 (es) 1985-05-01
ES8504775A1 ES8504775A1 (es) 1985-05-01

Family

ID=27023342

Family Applications (2)

Application Number Title Priority Date Filing Date
ES525490A Expired ES8502989A1 (es) 1982-09-09 1983-09-08 Un metodo de preparar compuestos de diaminopirimidina
ES531004A Expired ES8504775A1 (es) 1982-09-09 1984-03-27 Un metodo de preparar compuestos de diaminopirimidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES525490A Expired ES8502989A1 (es) 1982-09-09 1983-09-08 Un metodo de preparar compuestos de diaminopirimidina

Country Status (9)

Country Link
US (1) US4532240A (es)
EP (1) EP0103464B1 (es)
AU (2) AU560971B2 (es)
CA (1) CA1251447A (es)
DE (1) DE3378469D1 (es)
DK (1) DK158310C (es)
ES (2) ES8502989A1 (es)
GR (1) GR79058B (es)
IE (1) IE56148B1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
LU86695A1 (fr) * 1986-12-01 1988-07-14 Oreal Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique
HUT64323A (en) * 1992-06-09 1993-12-28 Richter Gedeon Vegyeszet Process for production new piperazinyl-bis(alkyl-amino)-pyrimidine derivatives
ATE166347T1 (de) * 1993-02-26 1998-06-15 Max Delbrueck Centrum Verfahren zur herstellung von c-nukleosiden und c-nukleosid-analoga, neue c-nukleoside und c- nukleosid-analoga, sowie ihre verwendung
DE4320570C2 (de) * 1993-02-26 2002-07-11 Max Delbrueck Centrum Verfahren zur Herstellung von C-Nukleosiden und C-Nukleosid-Analoga, neue C-Nukleoside und C-Nukleosid-Analoga sowie deren Verwendung
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
AU2076299A (en) 1998-01-30 1999-08-16 Meiji Seika Kaisha Ltd. Phenylpiperazine derivatives as integrin alphavbeta3 antagonists
US20040006042A1 (en) * 1998-08-13 2004-01-08 Berry David Allen Diaminopyrimidines and combination therapies effective for treatment of P-glycoprotein positive cancers
AU4690999A (en) * 1998-08-13 2000-03-06 Warner-Lambert Company Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers
BR0209932A (pt) * 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
GB0412072D0 (en) * 2004-05-28 2004-06-30 Syngenta Participations Ag Chemical compounds
JP6949055B2 (ja) * 2016-02-05 2021-10-13 ヴェラ ファーマシューティカルズ,エルエルシー 感染症を治療するための組成物および方法
WO2019032458A1 (en) * 2017-08-07 2019-02-14 Vyera Pharmaceuticals, LLC DHFR INHIBITORS, COMPOSITIONS AND RELATED METHODS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US416404A (en) 1889-12-03 Automatic lath-feeder for paper-carriers
BE485737A (es) * 1947-11-12
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
AT340933B (de) * 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines

Also Published As

Publication number Publication date
EP0103464A3 (en) 1985-07-03
DK407383A (da) 1984-03-10
DK158310C (da) 1990-10-15
AU6878787A (en) 1987-05-14
US4532240A (en) 1985-07-30
CA1251447A (en) 1989-03-21
GR79058B (es) 1984-10-02
EP0103464B1 (en) 1988-11-17
ES525490A0 (es) 1985-02-01
AU568997B2 (en) 1988-01-14
ES8502989A1 (es) 1985-02-01
DK158310B (da) 1990-04-30
DE3378469D1 (en) 1988-12-22
IE831920L (en) 1984-03-09
AU1869983A (en) 1984-03-15
EP0103464A2 (en) 1984-03-21
DK407383D0 (da) 1983-09-08
IE56148B1 (en) 1991-05-08
AU560971B2 (en) 1987-04-30
ES8504775A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
KR840005446A (ko) N--4-피페리딘아민의 제조방법
DK350083A (da) Fremgangsmaade til fremstilling af phenylethanolaminer
DK301986D0 (da) Fremgangsmaade til fremstilling af 1-hydroxyvitamin-d-forbindelser
ES500638A0 (es) Un metodo de preparacion de compuestos de sulfonilo
DK174383D0 (da) Fremgangsmade til fremstilling af et phenylalkylaminoethylsalicylamid
ES532509A0 (es) Un metodo de preparar dihidrobenzopirrolbenzodiazepinas
ES525490A0 (es) Un metodo de preparar compuestos de diaminopirimidina
ES525882A0 (es) Un metodo de formar articulos afieltrados
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
ES529031A0 (es) Un metodo de preparar nuevos compuestos de benzoilurea
ES538891A0 (es) Un metodo de preparar un compuesto de beta-fluoropiridina
ES530014A0 (es) Un metodo de preparar derivados de 4-quinolona
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK40883A (da) Fremgangsmaade til fremstilling af benzothienylallylaminer
DK424083D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
ES281866Y (es) Un conjunto de herramienta
ES499135A0 (es) Un metodo de preparar tiosemicarbazonas sustituidas
DK518883D0 (da) Fremgangsmade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK457983D0 (da) Fremgangsmade til fremstilling af beta-lactam
DK219483D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK399783A (da) Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
DK299083A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
KR840004092A (ko) N-치환-테트라하이드로티아진의 제조방법
DK385983A (da) Fremgangsmaade til fremstilling af 1-oxacephamer
DK535083A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040216